HOME >> MEDICINE >> NEWS
Drug for erectile dysfunction appears safe for some men with congestive heart failure

CHICAGO Carefully selected men with congestive heart failure appear to be able to safely take sildenafil, a drug used to treat erectile dysfunction (ED), if they are not taking nitrates to treat their heart condition, and have no evidence of myocardial ischemia, according to an article in the March 8 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

Erectile dysfunction affects an estimated 52 percent of men aged 40 to 70, is common in patients with congestive heart failure (CHF), and is associated with symptoms of depression, according to the article. Reports of deaths associated with sildenafil caused some physicians not to prescribe the drug to patients with heart disease. Sildenafil can decrease blood pressure in patients who take nitrates, and should not be taken by this group, the article states.

Linda J. Webster, M.Sc.N., of the University of Alberta, Edmonton, Canada, and colleagues studied the effectiveness and safety of sildenafil among 35 carefully selected men with CHF who did not use nitrates. The men were randomly assigned to one of two groups: one group took sildenafil for six weeks, then switched to a placebo for another six weeks. The other group started with placebo for six weeks, then switched to sildenafil for the remainder of the 12-week study. Follow-up visits took place at 2, 4, 6, 8, 10, and 12 weeks.

The researchers found even though sildenafil caused a slight reduction in blood pressure, no patient in the study experienced a dangerous drop in blood pressure while taking sildenafil. In addition, sildenafil improved erectile dysfunction and also appeared to reduce depression.

"The major finding of this study is that sildenafil is safe and effective in treating ED in men with moderate heart failure who undergo appropriate screening," write the authors.

"Although the use of sildenafil in patients with CHF at present is considered a relative contraindication, our f
'"/>

Contact: Phoebe Dey
780-492-0437
JAMA and Archives Journals
8-Mar-2004


Page: 1 2

Related medicine news :

1. More precise radiation therapy lets prostate cancer patients avoid erectile dysfunction
2. First ethnicity-specific erectile dysfunction study shows prevalence among Hispanic American men
3. Univ. of Pittsburgh researcher presents six-year results of botox injections for bladder dysfunction
4. Trials launched to test treatment of cognitive dysfunction in schizophrenia
5. Erectile dysfunction has devastating effect on morale
6. fMRI depicts multisensory dysfunction in people with dyslexia
7. Popular long-acting contraceptive linked to vascular dysfunction
8. Sensitivity to gluten may result in neurological dysfunction; independent of symptoms
9. Yale researchers create topical estrogen that alleviates sexual dysfunction in menopausal women and eliminates side effects of conventional estrogen
10. Use of cell phone images appears feasible for visualizing leg wounds
11. Over-the-counter supplement appears effective in treatment of midlife-onset depression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... ... March 30, 2017 , ... Nutrition Education for the ... (AND), will join nonprofit Seafood Nutrition Partnership (SNP) in presenting “Eating Heart Healthy: ... help nutrition educators and students inform consumers about the health benefits of eating ...
(Date:3/30/2017)... ... March 30, 2017 , ... This ... to President Trump expressing their support for an independent Vaccine Safety Commission. Five ... and one medical journalist, will hold a press conference at 9:00 AM ...
(Date:3/29/2017)... ... March 29, 2017 , ... ARI Network Services, Inc. (NASDAQ: ... co-op eligible dealer websites for its network of more than 650 U.S.-based dealers. Rhino, ... agricultural equipment including rotary and flail mowers and cutters, rear blades, post hole diggers, ...
(Date:3/29/2017)... New York City, NY (PRWEB) , ... March ... ... governing body for men’s and women’s professional squash, announced it has enlisted New ... marketing partner. The agency will develop and procure sponsorship opportunities for the ...
(Date:3/29/2017)... ... ... is the main cause of hay fever in the United States, with an estimated 95 ... May to July each year; with the worst time for sufferers being June and July. ... http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in independent studies ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... -- The new research portal will provide ... of company reports on UnitedHealth Group , as ... activities in the healthcare industry. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... through a fundamental transformation globally-a shift from a volume-based ...
(Date:3/30/2017)... Mass. , March 30, 2017  Akcea Therapeutics, ... announced the initiation of a Phase 2b dose-ranging study ... established cardiovascular disease. The goal of the study is ... of AKCEA-APO(a)-L Rx in a planned Phase 3 ... is part of Akcea,s strategic collaboration with Novartis to ...
(Date:3/30/2017)... 2017 Research and Markets has announced ... Size & Forecast, By Type (Hemodialysis, Peritoneal Dialysis), By Product ... From 2014 To 2025" report to their offering. ... The ... USD 108.5 billion by 2025. Home-based ...
Breaking Medicine Technology:
Cached News: